Skip to Main Content

Paper Details

Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy.
Oncotarget
5
2019
Author NameAffiliation
Jan MeinersVisceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg-Eppendorf
Claudia Hube-MaggInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Martina KluthInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Ronald SimonInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Hartwig HulandMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Markus GraefenMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Thorsten SchlommMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Thorsten SchlommCharite - Universitatsmedizin Berlin
Guido SauterInstitute of Pathology, University Medical Center Hamburg-Eppendorf
  • 1 - 9

Datasets